Emicizumab (Hemlibra®) for the prophylactic treatment of bleeding in patients with severe haemophilia A without inhibitors
Wijma S, De Boer J
Record ID 32018001077
Dutch
Original Title:
Package advice emicizumab (Hemlibra®)
Authors' objectives:
Package advice emicizumab Hemlibra
Details
Project Status:
Completed
Year Published:
2020
URL for published report:
https://english.zorginstituutnederland.nl/publications/reports/2020/02/17/emicizumab-hemlibra
Requestor:
National Health Care Institute
English language abstract:
An English language summary is available
Publication Type:
Other
Country:
The Netherlands
MeSH Terms
- Drug Therapy, Combination
- Blood Coagulation Factors
- Hemophilia A
- Antibodies, Monoclonal, Humanized
- Antibodies, Bispecific
Keywords
- emicizumab
- Hemlibra
Contact
Organisation Name:
The National Health Care Institute (ZIN, Zorginstituut Nederland)
Contact Address:
Postbus 320, NL-1110 AH Diemen The Netherlands
Contact Name:
Timon Sibma
Contact Email:
TSibma@zinl.nl
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.